Exact Sciences Corp (EXAS) Posts Q2 Loss of 24c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Wall Street mixed as oil prices surge, investors await earnings, economic data
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
- One dead in new attack on Saudi airport, a day after Houthi strike kills 13
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Getty Images to go private via prepackaged Chapter 11 restructuring
- Lumentum shares fall after hitting 52-week high
Exact Sciences (EXAS) PT Bumped at Jefferies Post Q2
July 23, 2014 8:55 AM EDTJefferies analyst Brandon Couillard raised his price target but lowered estimates on Buy-rated Exact Sciences (NASDAQ: EXAS) following Q2 results.
Couillard comments, "EXAS' 2Q14 earnings call served as a forum for it to provide an update on the anticipated timing of upcoming FDA &... More



